Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.

MLA

Lalonde, Chloe S., et al. “Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.” The Oncologist, vol. 28, no. 12, Dec. 2023, pp. 1055–63. EBSCOhost, https://doi.org/10.1093/oncolo/oyad181.

APA

Lalonde, C. S., Switchenko, J. M., Behera, M., Bilen, M. A., Owonikoko, T. K., Kaufman, J. L., Nooka, A. K., Lewis, C. M., Hitron, E., Collins, H., Judson, E. C., Alese, O. B., Donald Harvey, R., & Carlisle, J. W. (2023). Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast. The Oncologist, 28(12), 1055–1063. https://doi.org/10.1093/oncolo/oyad181

Chicago

Lalonde, Chloe S, Jeffrey M Switchenko, Madhusmita Behera, Mehmet A Bilen, Taofeek K Owonikoko, Jonathan L Kaufman, Ajay K Nooka, et al. 2023. “Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.” The Oncologist 28 (12): 1055–63. doi:10.1093/oncolo/oyad181.